Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MGX

Metagenomi Therapeutics Inc

May 22 • 04:00PM ET

1.35

+0.04 3.05 %

Healthcare • Biotechnology • USA • Micro • NASD

Peers: CRBU PRME EDIT BEAM NTLA

| Held by: VTI VXF IWC

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-2.29	Insider Own	31.03%	Shs Outstand	37.65M	Perf Week	3.05%
Market Cap	50.82M	Forward P/E	-	EPS next Y	-1.57	Insider Trans	-0.14%	Shs Float	25.96M	Perf Month	-5.59%
Enterprise Value	-50.15M	PEG	-	EPS next Q	-0.58	Inst Own	17.44%	Short Float	6.89%	Perf Quarter	-4.26%
Income	-85.89M	P/S	2.28	EPS this Y	10.01%	Inst Trans	-1.22%	Short Ratio	8.52	Perf Half Y	-16.15%
Sales	22.33M	P/B	0.37	EPS next Y	26.30%	ROA	-34.71%	Short Interest	1.79M	Perf YTD	-16.67%
Book/sh	3.66	P/C	0.36	EPS next 5Y	2.65%	ROE	-49.02%	52W High	3.95 -65.82%	Perf Year	-19.16%
Cash/sh	3.72	P/FCF	-	EPS past 3/5Y	-26.57% -42.49%	ROIC	-50.27%	52W Low	1.24 8.87%	Perf 3Y	-
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	13.59% 219.15%	Gross Margin	76.56%	Volatility	4.59% 4.74%	Perf 5Y	-
Dividend TTM	-	EV/Sales	-2.25	EPS Y/Y TTM	-9.30%	Oper. Margin	-415.48%	ATR (14)	0.07	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	6.43	Sales Y/Y TTM	-50.66%	Profit Margin	-384.61%	RSI (14)	47.45	Recom	1.50
Dividend Gr. 3/5Y	- -	Current Ratio	6.43	EPS Q/Q	9.28%	SMA20	-1.21%	Beta	0.64	Target Price	8.00
Payout	-	Debt/Eq	0.28	Sales Q/Q	-69.76%	SMA50	-3.25%	Rel Volume	0.84	Prev Close	1.31
Employees	119	LT Debt/Eq	0.24	Earnings	May 11 AMC	SMA200	-24.76%	Avg Volume	209.89K	Price	1.35
IPO	Feb 09, 2024	Option/Short	No / Yes	EPS/Sales Surpr.	-10.23% -78.86%	Trades		Volume	175,305	Change	3.05%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)